{"raw_mentions": "There are no sentences in the provided text that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nTABLE 1\n4\u20031008 \u00b1 68 nM2850 \u00b1 179 nM\n5\u2002<sup>\u2009</sup>202.5 \u00b1 83 nM84.3 \u00b1 8.1 nM\n6\u200310333 \u00b1 2375 nM7347 \u00b1 1092 nM\n7\u200316810 \u00b1 15190 nM23900 \u00b1 13670 nM\n8\u200312430 \u00b1 3744 nM47570 \u00b1 14790 nM\n9\u2003>100 \u03bcM>100 \u03bcM\n12\u2002>100 \u03bcM>100 \u03bcM\n13\u2002>100 \u03bcM>100 \u03bcM\nAtropine (1)0.43 \u00b1 0.1 nM6.00 \u00b1 1.1 nM\n\n\nNote that only the rows from Table 1 are extracted, as they contain specific molecule names (e.g. \"4\", \"5\", etc.), bioactivity metrics (Ki), numeric values, and units (nM)."}
{"final_json": [{"molecule_name": "4", "protein_target_name": null, "binding_metric": "Ki", "value": "1008 \u00b1 68", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "4", "protein_target_name": null, "binding_metric": "Ki", "value": "2850 \u00b1 179", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "5", "protein_target_name": null, "binding_metric": "Ki", "value": "202.5 \u00b1 83", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "5", "protein_target_name": null, "binding_metric": "Ki", "value": "84.3 \u00b1 8.1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "6", "protein_target_name": null, "binding_metric": "Ki", "value": "10333 \u00b1 2375", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "6", "protein_target_name": null, "binding_metric": "Ki", "value": "7347 \u00b1 1092", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "7", "protein_target_name": null, "binding_metric": "Ki", "value": "16810 \u00b1 15190", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "7", "protein_target_name": null, "binding_metric": "Ki", "value": "23900 \u00b1 13670", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "8", "protein_target_name": null, "binding_metric": "Ki", "value": "12430 \u00b1 3744", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "8", "protein_target_name": null, "binding_metric": "Ki", "value": "47570 \u00b1 14790", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "9", "protein_target_name": null, "binding_metric": "Ki", "value": ">100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "9", "protein_target_name": null, "binding_metric": "Ki", "value": ">100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "12", "protein_target_name": null, "binding_metric": "Ki", "value": ">100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "12", "protein_target_name": null, "binding_metric": "Ki", "value": ">100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "13", "protein_target_name": null, "binding_metric": "Ki", "value": ">100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "13", "protein_target_name": null, "binding_metric": "Ki", "value": ">100", "unit": "\u03bcM", "is_logarithmic": false}, {"molecule_name": "Atropine (1)", "protein_target_name": null, "binding_metric": "Ki", "value": "0.43 \u00b1 0.1", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "Atropine (1)", "protein_target_name": null, "binding_metric": "Ki", "value": "6.00 \u00b1 1.1", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIt was additionally observed that exo-8-benzyloxymethyl-3-ethoxycarbonyl-4-hydroxy-1-azabicyclo[3.3.1]non-3-ene (compound 5) functioned as a muscarinic receptor antagonist with a Ki only 14-fold greater than atropine at the human M2 receptor.\nA membrane suspension containing approximately 200 fmol of receptor was pre-incubated with 1 \u03bcM AMP-PNP for 15 min at 4\u00b0 C.\nPurified G\u03b1<sub>i1 </sub>and \u03b2<sub>1\u03b32 </sub>were added to a final concentration of 10 nM followed by the addition of concentrated GDP for a final concentration of 50 nM.\nThe assay was initiated by the addition of the appropriate ligand followed by [<sup>35</sup>S]GTP\u03b3S to a final concentration of approximately 7 nM and the incubation continued at 25\u00b0 C. for 2 min.\nFIG. 4 illustrates the functional activity of analogues at the human M2 receptor: [<sup>35 </sup>S]GTP\u03b3S binding assays were carried out in Sf9 cell membranes expressing the M2 muscarinic receptor in the presence of increasing concentrations of carbachol (Carb) or 100 \u03bcM of compound 4, 5, or 6."}
{"final_json": [{"molecule_name": "compound 5", "protein_target_name": "human M2 receptor", "binding_metric": "Ki", "value": "14-fold greater than atropine", "unit": null, "is_logarithmic": false}]}
